在非小细胞肺癌中对药物组合的反应的景观
Nishanth Ulhas Nair1, Patricia Greninger2, Xiaohu Zhang3
1Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
结合抗癌药物显示在非小细胞肺癌中具有不同的疗效. 向功能相关基因为开发更有效的抗癌药物组合提供了一个有希望的策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 基因组学就是基因组学.
背景情况:
- 单一的抗癌药物往往具有有限的疗效.
- 开发有效的药物组合是癌症治疗的一个重大挑战.
研究的目的:
- 选大量针对性药物组合的数据集,以检测非小细胞肺癌 (NSCLC).
- 确定设计更有效的抗癌药物组合的策略.
主要方法:
- 选了超过5000种针对性药物组合.
- 在81个非小细胞肺癌细胞系中测试组合.
- 分析响应异质性,并确定协同活动的模式.
主要成果:
- 在NSCLC模型中观察到药物反应的深刻异质性.
- 组合药物很少表现出比单一药物显著更大的疗效.
- 共同准功能近端基因更频繁地与增强的活动有关.
结论:
- 药物组合的疗效高度取决于特定的环境,这表明瘤特异性疗法的潜力.
- 针对功能相关基因是改善组合疗法设计的可行策略.
- 该数据集为了解癌症组合疗法的挑战和机遇以及开发预测计算模型提供了资源.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
